Probiotics in severe acute pancreatitis

The Lancet

Volumn 371, Issue 9613, 2008, Pages 634-635

  Sand, Juhani ^a   Nordback, Isto ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ACUTE HEMORRHAGIC PANCREATITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ELECTIVE SURGERY; ENTERIC FEEDING; HUMAN; INFECTION; INTESTINE FLORA; INTESTINE ISCHEMIA; LACTIC ACID BACTERIUM; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

EID: 39449132173     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60284-6     Document Type: Note

References (8)

1. Besselink M., van Santvoort H., Buskens E., et al., for the Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008) 651-659
2. UK Working Party on Acute Pancreatitis. UK guidelines for the management of acute pancreatitis. Gut 54 suppl 3 (2005) 1-9
3. Mazaki T., Ishii Y., and Takayama T. Meta-analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Br J Surg 93 (2006) 674-684
4. Rayes N., Seefhofer D., Theruvath T., et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg 246 (2007) 36-41
5. Olah A., Belagyi T., Issekutz A., Gamal M., and Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 89 (2002) 1103-1107
6. Timmerman H., Niers L., Ridwan B., et al. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr 26 (2007) 450-459
7. Ridwan B., Koning C., Besselink M., et al. Antimicrobial activity of a multispecies probiotic (Ecologic 641) against pathogens isolated from infected pancreatic necrosis. Lett Appl Microbiol 46 (2008) 61-67
8. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001. On the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official J Eur Comm 2001; 1.5.2001 http://www.eortc.be/Services/Doc/clinical-EU-directive-04-April-01.pdf (accessed Feb 9, 2008).